Sen. Manchin Presses FDA on Failure to Address Infant Formula Shortage, Calls for Reforms to Improve Future Responses
May 18, 2022
May 18, 2022
WASHINGTON, May 18 -- Sen. Joe Manchin, D-West Virginia, issued the following news release on May 17, 2022:
U.S. Senator Joe Manchin (D-WV) pressed Food and Drug Administration (FDA) Commissioner Robert M. Califf on the FDA's failure to address the nationwide infant formula shortage. Senator Manchin highlighted consumer complaints and contamination risks at Abbott Nutrition's facility in Sturgis, Michigan dating back to September 2019 and the FDA's inaction in address . . .
U.S. Senator Joe Manchin (D-WV) pressed Food and Drug Administration (FDA) Commissioner Robert M. Califf on the FDA's failure to address the nationwide infant formula shortage. Senator Manchin highlighted consumer complaints and contamination risks at Abbott Nutrition's facility in Sturgis, Michigan dating back to September 2019 and the FDA's inaction in address . . .